INTRODUCTION
In the present advanced and industrialized society, the three causes of death in order of frequency are Ischaemic Heart Disease (IHD), Diabetes mellitus and Cerebrovascular accidents. The prevalence of IHD has been reported to be as high as 50% among diabetes as per date of American Diabetic Associations (Vttilingam, K. et al, 1964) . Major risk factors for IHD are diabetes mellitus and atherosclerosis (Kanne et al, 1977) . The control of diabetes and hyperlipidemia is always useful in the prevention and treatment of IHD. The present work is an attempt to find out a safe, simple and reliable drug for the treatment of IHD in diabetic patients.
The herbal drug Kushtha (Saussurea lappa) has been widely referred by many classics of Indian Medicine (Sanghita as well as Chikitsa granthas). The drug is indicated in the disease like skin, obesity, heart, madhumeha (diabetes), svaskas and aphrodisiac tonic. This drug has been claimed to be antiallergic (Chopra, R.N., 1930 , 1983) . So the present work has been undertaken and drug kushtha (S.lappa) has been selected for further study to establish its effect in patients of IHD for comparison a known vasodilator drug segontin (Prenylominelactate 500 mg) has been taken.
MATERIALS AND METHODS
The present study induced 45 patients suffering from IHD the cases were selected from those attending the diabetic clinic, S.S. Hospital, I.M.S., B.H.U., Varanasi. The diagnosis of diabetes mellitus was made by the standard oral glucose tolerance test (National Diabetic Data) and IHD on clinical grounds. The cases were divided into three groups (n=15 in each), group I was treated with Kushtha alone, group II was treated with Kushtha + Segontin and group III was received segontin alone. 
RESULTS AND DISCUSSION
Among the patients who were studied, 32 were males and 13 were females of age 30 -65 years. It is evident from the Before the treatment there were 30 cases who showed precardial pain, dysponea and palpitation by walking fast or walking uphill or after full stomach. The rest 15 cases were having symptoms even of slow or walking at an average speed usually within 300 yards. After 4 months of treatment in group I, the response was significant in 1 case, moderate in 7 cases and there was no response in 7 cases.
Similarly in the group II (Kushtha + Segontin) significant response was observed in 7 cases, moderate in 6 cases and no response in two cases. Whereas in group III that is on segontin alone the response was significant in 2 cases, moderate in 11 cases and no response in 2 cases. These observations clearly show the effectiveness of the combined group i.e II (Table No. 2). When statically evaluated, the reduction in S. Cholesterol and S. triglycerides was significant (n<0.009). While comparing three groups the reduction was highly significant (P<0.001) in group II. These findings were similar with our previous experimental study. Table 5 showed the ECG changes in all 45 patients. Before the treatment, there was ST depression and T wave inversion in different leads according to the site of lesion. After therapy for 4 months 26 cases showed significant response, 10 cases moderate response and the remaining 9 cases showed no response (Table 6 ). While comparing the ECG improved in all three groups, 80% cases of combined group II showed significant response. As an illustration the ECG on one case is being given. As regards the dose it was observed the few patient of segontin group required maximum dose of 3 tab. Thrice a day whereas in combination with Kushtha the dose of segontin was only 1 tab. Twice a day. Side effects, i.e., G.I.T. disturbances headache, dizziness, nervousness etc. were noted in 36 patients of segontin alone treated group III, while in combined group no major side effects was noted except mile sedation and lassitude this may be because of small of drug of segontin. Similarly in group I, Kushtha treated only one case observed with the symptom of diarrhea (Table 7) .
Overall assessment of the response of clinical symptoms, biochemical parameters and ECG, significant improvement was observed in the 65% cases of combined group. These results suggested that therapy with the lipid lowering drug Kushtha also improves coronary circulation and myocardial functions. 
